112 related articles for article (PubMed ID: 38506070)
1. Retraction: Long non-coding RNA LINC00607 silencing exerts antioncogenic effects on thyroid cancer through the CASP9 promoter methylation.
J Cell Mol Med; 2024 Apr; 28(7):e18251. PubMed ID: 38506070
[No Abstract] [Full Text] [Related]
2. Long non-coding RNA LINC00607 silencing exerts antioncogenic effects on thyroid cancer through the CASP9 Promoter methylation.
Li L; Gao Z; Zhao L; Ren P; Shen H
J Cell Mol Med; 2021 Aug; 25(16):7608-7620. PubMed ID: 34232553
[TBL] [Abstract][Full Text] [Related]
3. Silencing of Long Non-Coding RNA LINC00607 Prevents Tumor Proliferation of Osteosarcoma by Acting as a Sponge of miR-607 to Downregulate E2F6.
Zheng Y; Chen Z; Zhou Z; Xu X; Yang H
Front Oncol; 2020; 10():584452. PubMed ID: 33585204
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway.
Weng YC; Ma J; Zhang J; Wang JC
Cancer Biol Ther; 2019; 20(3):368-380. PubMed ID: 30580676
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer.
Zhang L; Liu H; Long Y; Zhang Y
Open Med (Wars); 2023; 18(1):20230649. PubMed ID: 37333453
[TBL] [Abstract][Full Text] [Related]
6. MYC-activated LINC00607 promotes hepatocellular carcinoma progression by regulating the miR-584-3p/ROCK1 axis.
Dong S; Wang W; Liao Z; Fan Y; Wang Q; Zhang L
J Gene Med; 2023 Apr; 25(4):e3477. PubMed ID: 36740760
[TBL] [Abstract][Full Text] [Related]
7. Vascular Regulation by Super Enhancer-Derived LINC00607.
Sriram K; Luo Y; Yuan D; Malhi NK; Tapia A; Samara VA; Natarajan R; Bouman Chen Z
Front Cardiovasc Med; 2022; 9():881916. PubMed ID: 35837599
[TBL] [Abstract][Full Text] [Related]
8. The endothelial-enriched lncRNA LINC00607 mediates angiogenic function.
Boos F; Oo JA; Warwick T; Günther S; Izquierdo Ponce J; Lopez M; Rafii D; Buchmann G; Pham MD; Msheik ZS; Li T; Seredinski S; Haydar S; Kashefiolasl S; Plate KH; Behr R; Mietsch M; Krishnan J; Pullamsetti SS; Bibli SI; Hinkel R; Baker AH; Boon RA; Schulz MH; Wittig I; Miller FJ; Brandes RP; Leisegang MS
Basic Res Cardiol; 2023 Jan; 118(1):5. PubMed ID: 36700983
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA LINC00673 silencing inhibits proliferation and drug resistance of prostate cancer cells via decreasing KLF4 promoter methylation.
Jiang Z; Zhang Y; Chen X; Wu P; Chen D
J Cell Mol Med; 2020 Jan; 24(2):1878-1892. PubMed ID: 31881124
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer.
Ooizumi Y; Katoh H; Yokota M; Watanabe M; Yamashita K
Oncotarget; 2019 Oct; 10(57):5906-5918. PubMed ID: 31666923
[TBL] [Abstract][Full Text] [Related]
11. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
[TBL] [Abstract][Full Text] [Related]
12. Silencing long non-coding RNA HOTAIR exerts anti-oncogenic effect on human acute myeloid leukemia via demethylation of HOXA5 by inhibiting Dnmt3b.
Wang SL; Huang Y; Su R; Yu YY
Cancer Cell Int; 2019; 19():114. PubMed ID: 31168296
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.
Peng X; Ji C; Tan L; Lin S; Zhu Y; Long M; Luo D; Li H
J Cell Mol Med; 2020 Jan; 24(1):304-316. PubMed ID: 31657132
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter.
Gao LM; Xu SF; Zheng Y; Wang P; Zhang L; Shi SS; Wu T; Li Y; Zhao J; Tian Q; Yin XB; Zheng L
J Cell Mol Med; 2019 Sep; 23(9):6411-6428. PubMed ID: 31317666
[TBL] [Abstract][Full Text] [Related]
15. Downregulated long noncoding RNA LINC00313 inhibits the epithelial-mesenchymal transition, invasion, and migration of thyroid cancer cells through inhibiting the methylation of ALX4.
Zhao X; Hu X
J Cell Physiol; 2019 Nov; 234(11):20992-21004. PubMed ID: 31093972
[TBL] [Abstract][Full Text] [Related]
16. Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1.
Gao J; Dai C; Yu X; Yin XB; Liao WJ; Huang Y; Zhou F
Gene Ther; 2021 Jun; 28(6):306-318. PubMed ID: 32917950
[TBL] [Abstract][Full Text] [Related]
17. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
18. SOCS3 gene silencing does not occur through methylation and mutations in gastric cancer.
Al Saqri A; Malgundkar SH; Al Kindi F; Gupta I; Al Moundhri M; Tamimi Y
Hum Cell; 2022 Jul; 35(4):1114-1125. PubMed ID: 35596898
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA BZRAP1-AS1 silencing suppresses tumor angiogenesis in hepatocellular carcinoma by mediating THBS1 methylation.
Wang W; Chen G; Wang B; Yuan Z; Liu G; Niu B; Chen Y; Zhou S; He J; Xue H
J Transl Med; 2019 Dec; 17(1):421. PubMed ID: 31847842
[TBL] [Abstract][Full Text] [Related]
20. Replication of a pathogenic non-coding RNA increases DNA methylation in plants associated with a bromodomain-containing viroid-binding protein.
Lv DQ; Liu SW; Zhao JH; Zhou BJ; Wang SP; Guo HS; Fang YY
Sci Rep; 2016 Oct; 6():35751. PubMed ID: 27767195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
